Insulin Resistance Health Article

PERIODICALS

Brame, L., S. Verma, T. Anderson, A. Lteif, and K. Mather. "Insulin resistance as a therapeutic target for improved endothelial function: metformin." Curr Drug Targets Cardiovasc Haematol Disord (March 2004): 53–63.

Camp, H. S. "Thiazolidinediones in diabetes: current status and future outlook." Curr Opin Investig Drugs (April 2003): 406–11.

Cargo, D. M. "Association between smoking, insulin resistance and beta-cell function in a North-Western First Nation." Diabet Med (February 2004): 188–93.

Dzien, A., C. Dzien-Bischinger, F. Hoppichler, and M. Lechleitner. "The metabolic syndrome as a link between smoking and cardiovascular disease." Diabetes Obes Metab (March 2004): 127–32.

Nelson, M. R. "Managing 'metabolic syndrome' and multiple risk factors." Aust Fam Physician (April 2004): 201–5. Osei, K, S. Rhinesmith, T. Gaillard, and D. Schuster. "Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 diabetes." Metabolism (April 2004): 414–22.

Scheen, J. "Current management strategies for coexisting diabetes mellitus and obesity." Drugs (2003): 1165–84.

Yamamoto, Y., I. Sogawa, A. Nishina, S. Saeki, N. Ichikawa, and S. Iibata. "Improved hypolipidemic effects of xanthan gum-galactomannan mixtures in rats." Biosci Biotechnol Biochem (October 2000): 2165–71.

ORGANIZATIONS

American Association of Clinical Endocrinologists (AACE). 1000 Riverside Avenue, Suite 205, Jacksonville, FL 32204.

National Organization for Rare Disorders. 55 Kenosia Avenue, PO Box 1968, Danbury, CT 06813-1968.

Samuel Uretsky, Pharm.D.